12:00 AM
Jan 05, 2009
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Paladin, ProStrakan sales and marketing update

ProStrakan granted Paladin exclusive rights to market Abstral fentanyl and Sancuso granisetron patch in Canada for an undisclosed upfront payment and...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >